Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: London
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Epistem Holdings PLC

+ Add to Watchlist


272.500 GBp 0.0000.00%

As of 11:35:27 ET on 01/29/2015.

Snapshot for Epistem Holdings PLC (EHP)

Open: 272.500 Day's Range: 272.500 - 272.500 Volume: 0
Previous Close: 272.500 52wk Range: 270.000 - 340.000 1-Yr Rtn: -15.50%

Stock Chart for EHP

No chart data available.
  • EHP:LN 272.500
  • 1D
  • 1M
  • 1Y
Interactive EHP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EHP

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. UKX -
Earnings Per Share (GBP) (ttm) -0.1730
Est. EPS (GBP) (06/2015) -0.3280
Est. PEG Ratio -
Market Cap (M GBP) 27.26
Shares Outstanding (M) 10.00
30 Day Average Volume 25,453
Price/Book (mrq) 2.5095
Price/Sale (ttm) 4.6154
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EHP

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for EHP

Epistem Holdings PLC is a biotechnology company that commercializes adult stem cells in the areas of oncology and gastrointestinal diseases as well as cosmeceutical applications. The Company develops therapeutics and diagnostic biomarkers and provides contract research services to drug development companies.

Matthew Heaton WallsChief Executive OfficerHugh John Joseph RylandsFinance Director/Secretary
Allan BrownCOO:DiagnosticsCatherine BoothMng Dir:Contract Research
More Company Profile & Key Executives for EHP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil